114 related articles for article (PubMed ID: 7053826)
61. Circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease. Their relationship to immune function.
Spinozzi F; Velardi A; Rambotti P; Losito A; Zampi I; Cernetti C; Gerli R; Martelli MF; Grignani F
J Clin Lab Immunol; 1983 Oct; 12(2):87-92. PubMed ID: 6644793
[TBL] [Abstract][Full Text] [Related]
62. Subpopulations of human thymus cells differing in their capacity to form stable E-rosettes and in their immunologic reactivity.
Galili U; Schlesinger M
J Immunol; 1975 Sep; 115(3):827-33. PubMed ID: 125304
[TBL] [Abstract][Full Text] [Related]
63. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
Hillinger SM; Herzig GP
J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
[TBL] [Abstract][Full Text] [Related]
64. Immunologic parameters in childhood Hodgkin's disease II. T and B lymphocytes in the peripheral blood of normal children and in the spleen and peripheral blood of children with Hodgkin's disease.
de Sousa M; Tan CT; Siegal FP; Filippa DA; Tan R; Good RA
Pediatr Res; 1978 Feb; 12(2):143-7. PubMed ID: 306089
[TBL] [Abstract][Full Text] [Related]
65. The effect of in vitro irradiation on mitogenic responsiveness of peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
Baral E; Blomgren H; Juhlin I
Cancer; 1979 Oct; 44(4):1241-6. PubMed ID: 498012
[TBL] [Abstract][Full Text] [Related]
66. Blood lymphocytes in chronic lymphocytic leukaemia and Hodgkin's disease: Immunological features and enzymes of nucleoside metabolism.
Ambrogi F; Grassi B; Ronca-Testoni S; Ronca G
Clin Exp Immunol; 1977 Apr; 28(1):80-8. PubMed ID: 405169
[TBL] [Abstract][Full Text] [Related]
67. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
Pappas A; Pees H; Girmann G
Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
[TBL] [Abstract][Full Text] [Related]
68. A prospective study of the changes in the immune status before, during, and after multiple-agent chemotherapy for Hodgkin's disease.
Van Rijswijk RE; Sybesma JP; Kater L
Cancer; 1983 Feb; 51(4):637-44. PubMed ID: 6821837
[TBL] [Abstract][Full Text] [Related]
69. Spleen lymphocyte populations in patients with Hodgkin's disease--properties of cells with different densities.
Rocha B; Ferreira AA; Munn G; de Sousa M; Freitas AA
Clin Exp Immunol; 1982 May; 48(2):300-6. PubMed ID: 7105487
[TBL] [Abstract][Full Text] [Related]
70. Multivariate analysis of T-cell functional defects and circulating serum factors in Hodgkin's disease.
Schulof RS; Bockman RS; Garofalo JA; Cirrincione C; Cunningham-Rundles S; Fernandes G; Day NK; Pinsky CM; Incefy GS; Thaler HT; Good RA; Gupta S
Cancer; 1981 Aug; 48(4):964-73. PubMed ID: 6456060
[TBL] [Abstract][Full Text] [Related]
71. [Effect of thymostimulin on thymic serum activity and the expression of E-receptor by guinea pig lymphocytes in late thymectomy].
Grinevich IuA; Fil'chakov FV; Gomberg EG
Fiziol Zh (1978); 1988; 34(2):79-84. PubMed ID: 3391311
[No Abstract] [Full Text] [Related]
72. Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease.
Sibbitt WL; Bankhurst AD; Williams RC
J Clin Invest; 1978 Jan; 61(1):55-63. PubMed ID: 304068
[TBL] [Abstract][Full Text] [Related]
73. Spontaneously DNA synthesizing blood and spleen lymphocytes in Hodgkin's disease.
Björkholm M; Holm G; Ljungdahl A; Strömberg M; Askergren J
Scand J Haematol; 1981 Feb; 26(2):97-105. PubMed ID: 7256215
[TBL] [Abstract][Full Text] [Related]
74. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
Pluzańska A
Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
[No Abstract] [Full Text] [Related]
75. Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.
Deshazo RD; Ewel C; Londono S; Metzger Z; Hoffeld JT; Oppenheim JJ
Clin Exp Immunol; 1981 Nov; 46(2):313-20. PubMed ID: 7337972
[TBL] [Abstract][Full Text] [Related]
76. Thymosin-induced increase in E-rosette-forming capacity of lymphocytes in patients with malignant neoplasms.
Sakal H; Costanzi JJ; Loukas DF; Gagliano RG; Ritzmann SE; Goldstein AL
Cancer; 1975 Sep; 36(3):974-6. PubMed ID: 1182684
[TBL] [Abstract][Full Text] [Related]
77. Zinc and anergy in pediatric Hodgkin's disease in Turkey.
Cavdar AO; Babacan E; Gözdaşoğlu S; Erten J; Cin S; Arcasoy A; Ertem U
Cancer; 1987 Jan; 59(2):305-9. PubMed ID: 3802017
[TBL] [Abstract][Full Text] [Related]
78. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
[TBL] [Abstract][Full Text] [Related]
79. In vitro effect of a bovine thymic extract (thymostimulin) on T-cell differentiation in cord blood lymphocytes.
Lin CY; Chu CM
Pediatr Pharmacol (New York); 1985; 5(3):181-7. PubMed ID: 3879346
[TBL] [Abstract][Full Text] [Related]
80. [The influence on PHA-stimulation by inhibition of prostaglandin synthesis in vitro in patients with Hodgkin's disease (author's transl)].
Pees HW; Girmann G; Schwamborn J
Blut; 1980 Apr; 40(4):239-47. PubMed ID: 7370437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
